Monitor for the release of the missing exhibit (EX-99.1) which may contain an investor presentation or preliminary financial results. Absent content, no trading decision should be made based on this filing alone.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 27 $6.12entry
- T+1 · 9mo ago −1.63%α −1.69% · $6.02
- T+5 · 9mo ago −5.07%α −3.08% · $5.81
- T+20 · 8mo ago −11.76%α −4.21% · $5.40
- T+60 · 6mo ago +2.29%α −7.10% · $6.26
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable. The 8-K filing for Xeris Biopharma Holdings, Inc. (XERS) includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), suggesting a possible investor presentation or public disclosure of material information, but no specific details or financial data are accessible to confirm content or implications.
Key Facts
- Filing is an 8-K for Xeris Biopharma Holdings, Inc. (XERS)
- Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
- No document content available to verify disclosures, financials, or strategic updates
- Exhibit 99.1 (press release or presentation) was likely filed but not accessible
Financial Impact
Not specified
Risk Factors
- Material information may have been disclosed that is not reflected in this analysis
- Potential for market-moving guidance or results being missed due to document unavailability
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
25 reports on XERS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers